在多发性骨髓瘤中,双特异性抗体点和治疗方法
Matthew Rees1,2, Nadine Abdallah1, Binoy Yohannan1,3
1Division of Hematology, Mayo Clinic, Rochester, MN, United States.
Frontiers in immunology
|October 25, 2024
概括
双特异性抗体 (BsAbs) 为复发性多发性髓瘤 (MM) 患者提供了新的希望,显示出高响应率. 然而,最佳使用,感染风险和耐药机制需要对这些新型疗法进行进一步的研究.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
背景情况:
- 双特异性抗体 (BsAbs) 已被批准用于复发性多发性骨髓瘤 (MM).
- 这些疗法在重度预治疗的患者中显示出高响应率和无进展生存率.
- BsAbs带来了新的治疗选择和临床决策挑战.
研究的目的:
- 审查MM中BsAbs的作用机制,治疗目标和组合方法.
- 检查与BsAb疗法相关的治疗序列和疾病复发机制.
- 讨论MM治疗开发中的新型T细胞参与剂.
主要方法:
- 对多发性骨髓瘤中双特异性抗体的当前文献的综述.
- 对临床试验数据关于BsAbs.有效性和安全性的分析.
- 检查新兴的耐药机制和新的治疗策略.
主要成果:
- 与CAR T细胞相比,BsAbs在复发的MM中表现出高疗效,细胞因子释放综合征和神经毒性率较低.
- 较高的感染发病率和新型耐药性途径与慢性BsAb疗法有关.
- 许多新的T细胞参与者正在接受调查,有希望的早期数据.
结论:
- BsAbs对于复发的MM有价值,但最佳的患者选择,测序和持续时间正在研究中.
- 管理感染风险和了解耐药性对于长期的BsAb疗效至关重要.
- 对新型BsAbs和T细胞参与剂的持续研究有望在MM治疗中取得进一步的进步.
相关概念视频
02:57Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
01:31Hybridoma Technology
14.1K
Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
14.1K
01:27Tumor Immunotherapy
486
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
486
02:50Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
02:49Cancer Therapies
7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K